Syros Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
21 Dec 23 | BuyUS$3,999,998 | Samsara BioCapital LLC | Company | 904,977 | US$4.42 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 418,218 | 1.56% |
Hedge Funds | 5,217,223 | 19.5% |
Institutions | 5,899,703 | 22.1% |
General Public | 6,658,693 | 24.9% |
VC/PE Firms | 8,534,500 | 31.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,749,808 | US$14.1m | 29.4% | 1.37% | |||
2,505,013 | US$12.9m | -29.8% | 0.38% | |||
2,071,914 | US$10.6m | 187% | 0.02% | |||
1,786,427 | US$9.2m | 103% | 1.81% | |||
1,673,538 | US$8.6m | 5.84% | 0.35% | |||
1,493,252 | US$7.7m | 0% | 2.62% | |||
1,471,771 | US$7.6m | 0% | 0.02% | |||
1,293,848 | US$6.6m | 30.2% | 0.46% | |||
764,812 | US$3.9m | 44.8% | no data | |||
531,914 | US$2.7m | 0% | 0.13% | |||
528,190 | US$2.7m | 0% | 0.17% | |||
359,370 | US$1.8m | 0% | 0.48% | |||
251,270 | US$1.3m | 0% | 0.89% | |||
246,944 | US$1.3m | 0.49% | no data | |||
239,681 | US$1.2m | 125% | no data | |||
214,885 | US$1.1m | -19.2% | 0.27% | |||
169,999 | US$872.1k | 576% | no data | |||
161,563 | US$828.8k | 17.2% | no data | |||
147,658 | US$757.5k | 47.5% | no data | |||
130,000 | US$666.9k | 0% | 0.06% | |||
103,522 | US$531.1k | -4.27% | 0.01% | |||
85,031 | US$436.2k | 0% | 0.05% | |||
84,002 | US$430.9k | 0% | 0.07% | |||
81,525 | US$418.2k | -9.59% | no data | |||
79,927 | US$410.0k | -24.6% | 0.15% |